Clinical Trial: A Study of Lutetium [177Lu]-BL-ARC001 in Patients With Locally Advanced or Metastatic Lung Cancer, Breast Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors

U.S., Dec. 11 -- ClinicalTrials.gov registry received information related to the study (NCT07274852) titled 'A Study of Lutetium [177Lu]-BL-ARC001 in Patients With Locally Advanced or Metastatic Lung Cancer, Breast Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors' on Nov. 27.

Brief Summary: This study is an open, multicenter, dose-escalation and cohort-expansion non-randomized phase I clinical trial to evaluate the safety, tolerability, pharmacokinetic characteristics and preliminary efficacy of Lutetium [177Lu] BL-ARC001 in patients with locally advanced or metastatic solid tumors.

Study Start Date: Dec., 2025

Study Type: INTERVENTIONAL

Condition: Lung Cancer Breast Cancer Head and Neck Squamous Cell Carcinoma Soli...